FCMV
Foresite Capital Management V Portfolio holdings
AUM
$271M
1-Year Est. Return
309.87%
This Fund
S&P 500
1 Year Est. Return
+309.87%
AUM
$271M
AUM Growth
+$107M
(+65%)
Holding
10
Top Buys
| 1 | +$17.6M | |
| 2 | +$11M | |
| 3 | +$5.2M | |
| 4 |
Pharvaris
PHVS
|
+$5.18M |
| 5 |
Nurix Therapeutics
NRIX
|
+$4.39M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALMS
1
Alumis Inc
ALMS
$2.57B
| $130M | 47.94% |
5,896,995
+117,647
|
|
||
2
CG Oncology
CGON
$4.97B
| $68M | 25.08% |
1,004,050
|
|
||
3
Disc Medicine
IRON
$2.61B
| $23.9M | 8.83% |
374,069
+75,000
|
|
||
4
Hims & Hers Health
HIMS
$6.11B
| $15.3M | 5.65% |
738,151
+465,000
|
|
||
|
EIKN
5
Eikon Therapeutics
EIKN
$494M
| $14M | 5.15% |
+1,318,983
|
|
||
6
Lyell Immunopharma
LYEL
$304M
| $9.57M | 3.53% |
477,078
|
|
||
|
7
Pharvaris
PHVS
$2.04B
| $5.48M | 2.02% |
+194,125
|
|
||
|
8
Nurix Therapeutics
NRIX
$1.67B
| $4.11M | 1.52% |
+265,000
|
|
||
|
MAZE
9
Maze Therapeutics
MAZE
$1.35B
| $773K | 0.29% |
25,905
-60,386
|
|
||
10
Natera
NTRA
$30B
| – | – |
-67,356
|
|